Penicillamine and Schizophrenia—A Clinical Trial
Authors:
- J. W. AffleckJAJ. W. Affleck
- A. J. CooperACA. J. Cooper
- A. D. ForrestAFA. D. Forrest
- J. R. SmythiesJSJ. R. Smythies
- A. K. ZealleyAZA. K. Zealley
- 1 February 1969
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 115 (519) , 173-176
Abstract
One specific hypothesis concerning the biochemical lesion in schizophrenia was put forward by McIsaac (1961) on the basis of the close chemical relationship between the pineal hormone melatonin and the hallucinogenic drug harmine. On this basis Nicholson et al. (1966) conducted a clinical trial of D-penicillamine plus a low copper diet in schizophrenics, with encouraging results. They used 1,200 mg. daily in a double-blind trial against placebo for six weeks. Hollister et al. (1966) also treated schizophrenic patients with D-penicillamine, but for a different reason—they suggested that depolymerization might be effective if schizophrenia is an autoimmune disorder. They used doses of 1,000 mg. daily for five weeks following an initial build up, and noted no clinical amelioration in 13 schizophrenics studied. A normal diet was given. Walshe (1967) failed to find any improvement in 4 chronic patients on penicillamine for one year.Keywords
This publication has 6 references indexed in Scilit:
- Antipyridoxine Effect of d-Penicillamine in Schizophrenic MenThe American Journal of Clinical Nutrition, 1966
- EFFECT OF PENICILLAMINE ON SCHIZOPHRENIC PATIENTSThe Lancet, 1966
- A Single-Patient, Self-Controlled and Self-Recorded Trial of Wy 3498The British Journal of Psychiatry, 1965
- A Biochemical Concept of Mental DiseasePostgraduate Medicine, 1961
- Statistical Inference and the Single Case in Clinical Design†Psychiatry, 1960
- A Controlled Trial of Thiopropazate Dihydrochloride (Dartalan), Chlorpromazine and Occupational Therapy in Chronic SchizophrenicsJournal of Mental Science, 1960